Pharmacokinetics of cefetamet in plasma and skin blister fluid

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 102-104

  Zimmerli, W ^a   Sansano, S ^a   Wittke, B ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANTHARIDIN; CEFACLOR; CEFALEXIN; CEFETAMET; CEFETAMET PIVOXIL; CEPHALOSPORIN DERIVATIVE; PENICILLIN BINDING PROTEIN;

ADULT; ARTICLE; BLISTER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG PROTEIN BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTERSTITIAL FLUID; MALE; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; BLISTER; CEFTIZOXIME; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXUDATES AND TRANSUDATES; HUMANS; MALE; PROTEIN BINDING;

EID: 0030050859     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Blouin, R. A., J. Kneer, and K. Stoeckel. 1989 Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects. Antimicrob Agents Chemother. 33:291-296.
2. Blouin, R. A., and K. Stoeckel. 1993. Cefetamet pivoxil clinical pharmacokinetics Clin Pharmacokinet 25:172-188
3. Bryson, H. M., and R. N. Brogden. 1993. Cefetamet pivoxil A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 45:589-621
4. Brodie, B. B., H. Kurz, and L. S. Schanker. 1960. The importance of the dissociation constant and lipid-solubility in influencing the passage of drugs into the cerebrospinal fluid. J. Pharmacol. Exp. Ther. 130:20-25.
5. Drusano, G. L. 1988. Role of pharmacokinetics in the outcome of infections Antimicrob. Agents Chemother. 32:289-297
6. Fassbender, M. L., H. Lode, T. Schaberg, K. Borner, and P. Koeppe. 1993. Pharmacokinetics of new oral cephalosporins, including a new carbacephem Clin. Infect. Dis 16:646-653.
7. Gibaldi, M., and D. Perrier. 1082. Pharmacokinetics, 2nd ed. Marcel Dekker, Inc., New York
8. Hoogkamer, J. F., W. H. Hesse, S. Sansano, and W. Zimmerli. 1993. Pharmacodynamic activity of a cephalosporin, Ro 40-6890, in human skin blister fluid: antibiotic activity in concert with host defense mechanisms. Antimicrob. Agents Chemother. 37:2622-2627
9. Kissling, M. 1992. Cefetamet pivoxil in community-acquired pneumonia: an overview. Curr. Med. Res. Opin. 12:631-639.
10. Nye, K., P. O'Neill, J. M. Andrews, and R. Wise. 1990 Pharmacokinetics and tissue penetration of cefprozil J. Antimicrob. Chemother. 25:831-835.
11. Ohmori, H., H. Kumon, Y. Kanemasa, Y. Hirai, and T. Saito. 1990. Study to find optimum dose of cefetamet pivoxil in complicated unnary tract infections. Jpn. J. Antibiot. 43:2102-2132.
12. O'Neill, P., K. Nye, G. Douce, J. M. Andrews, and R. Wise. 1990. Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers Antimicrob. Agents Chemother. 34:232-234
13. Schafer-Korting, M., and H. C. Korting. 1989. Skin blisters and skin windows: an access to total and free drug concentrations in the skin. Models Dermatol 4:45-62
14. Stone, J. W., G. Linong, J. M. Andrews, and R. Wise. 1989 Cefixime, in-vitro activity, pharmacokinetics and tissue penetration J. Antimicrob. Chemother. 23:221-228
15. Tam, Y. K., J. Kneer, U. C. Dubach, and K. Stoeckel. 1989. Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers. Antimicrob Agents Chemother. 33:957-959.
16. Tam, Y. K., J. Kneer, U. C. Dubach, and K. Stoeckel. 1990. Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers. Antimicrob. Agents Chemother. 34:1556-1559.
17. Then, R. L. 1987. Interaction of two new cephalosporins, cefetamet and ccftcram, with beta-lactamascs and penicillin binding proteins Prog. Antimicrob. Anticancer Chemother. 1:185-187.
18. Wise, R. 1986. Methods for evaluating the penetration of β-lactam antibiotics into tissues. Rev. infect. Dis. 8(Suppl. 3):S325-S332.
19. Wise, R. 1990. The pharmacokinctics of the oral cephalosporins - a review J. Antimicrob. Chemother. 26:13-20
20. Wise, R., S. A. Hennett, and J. Dent. 1984. The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanate. J Antimicrob Chemother. 13:603-610.
21. Wise, R., A. P. Gillet, B. Cadge, S. R. Durham, and S. Baker. 1980. The influence of protein binding upon tissue fluid levels of six β-lactam compounds. J. Infect Dis. 142:77-82.
22. Wise, R., K. Nye, P. O'Neill, M. Wostenholme, and J. M. Andrews. 1990. Pharmacokinetics and tissue penetration of ceftibuten. Antimicrob. Agents Chemother. 34:1053-1055.
23. Wyss, R., and F. Bucheli. 1988 Determination of cefetamet and its orally active ester, cefetamet pivoxil, in biological fluids by high-performance liquid chromatography J. Chromatogr. Biomed Appl. 430:81-92.